| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 03/28/2007 | EP1767215A1 Isoflavones against radiation-induced mortality |
| 03/28/2007 | EP1765385A1 Sustained release vaccine composition |
| 03/28/2007 | EP1765324A2 Compositions of stable bioactive metabolites of docosahexaenoic (dha) and eicosapentaenoic (epa) acids |
| 03/28/2007 | EP1500397B1 Adsorbents for oral administration, remedies or preventives for kidney diseases and remedies or preventives for liver diseases |
| 03/28/2007 | CN1938037A Adsorbent for oral administration and therapeutic agent or prophylactic agent for kidney disease and therapeutic agent or prophylactic agent for liver disease |
| 03/28/2007 | CN1935260A Human antibodies that bind human tnfalpha |
| 03/28/2007 | CN1935169A Bluish dogbane extract preparing method, and its medicinal preparation and use |
| 03/27/2007 | US7196118 Amidino compounds useful as nitric oxide synthase inhibitors |
| 03/27/2007 | US7195902 Expression vector comprising nucleotide sequences coding JNK activating phosphatase for use identifying modulator for treatment of inflammatory, arthritic, cardiovascular, respiratory cell proliferative and liver disorders |
| 03/27/2007 | US7195787 Topical cosmetic |
| 03/22/2007 | US20070065941 Nerve cells obtained by the method of the present invention have the flexibility to differentiate into a variety of types of neurons in vivo preferably without the need for application of growth factors; Embryonic Stem (ES) cells |
| 03/22/2007 | US20070065453 Transferrin-binding proteins from neisseria gonorrhoeae and neisseria meningitidis |
| 03/22/2007 | US20070065380 provitamin C is prepared from Lycium fruit extract; decomposed in the body to produce vitamin C; improved stability in the body and prolonged life in the body; bioavailability; vitamin C-fortified food; apply to skin protecting from ultraviolet damage, wrinkles and aging |
| 03/21/2007 | EP1764103A2 Crystalline amifostine compositions and methods for the preparation and use of same |
| 03/21/2007 | EP1764085A1 Cosmetic composition comprising argan oil |
| 03/21/2007 | CN1933823A Use of renin inhibitors in therapy |
| 03/21/2007 | CN1931249A Hypoxia resisting capsule |
| 03/21/2007 | CN1931219A Gynostemma pentaphylla micro emulsion medicine and its prepn |
| 03/21/2007 | CN1305502C Oral taken medicine for snakebite by long noded pit viper |
| 03/20/2007 | US7192975 Arylimidazole derivatives, preparation and therapeutic used thereof |
| 03/20/2007 | US7192929 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 03/15/2007 | WO2007029889A1 Protective action of serofendic acid on cardiac muscle |
| 03/15/2007 | US20070059369 Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders |
| 03/14/2007 | EP1762233A1 Preventitive for oxygen-induced damages from diving |
| 03/14/2007 | EP1761272A1 Compositions containing d-carnosine |
| 03/14/2007 | CN1927383A Compound recipe preparation for lowering oxidative stress rapidly and prepn. method therefor |
| 03/14/2007 | CN1927356A Oxidation resistance functional form health food for enhancing human body immunity |
| 03/14/2007 | CN1927312A Grape extract containing medicine composition and its preparation and use |
| 03/14/2007 | CN1927257A Antisenescence traditional Chinese medicine for and its preparation method |
| 03/14/2007 | CN1927202A Vitamin E nicotinate microcapsule and its preparing process |
| 03/14/2007 | CN1927182A Procyanidins nano milk-like liquid medicine and its preparation |
| 03/14/2007 | CN1304052C Medicinal compositions for application to mucosa |
| 03/14/2007 | CN1304009C Nutritional preparation comprising ribose and folic acid and medical use thereof |
| 03/14/2007 | CN1303990C Sodium ferulate oral disintegrating tablet and its preparation process |
| 03/13/2007 | US7189878 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 03/13/2007 | US7189707 Modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby processes in which such oxidants are a participant. The invention also relates to compounds and |
| 03/13/2007 | US7189395 Complexes of immunoglobulins and polysaccharides for oral and transmucosal absorption |
| 03/13/2007 | CA2373128C Tetrapeptide revealing geroprotective effect, pharmacological substance on its basis, and the method of its application |
| 03/13/2007 | CA2192209C Treatment of optic neuritis |
| 03/08/2007 | WO2007027118A1 Dermatological composition |
| 03/08/2007 | WO2006117181A3 Prophylaxis and treatment of diseases |
| 03/08/2007 | US20070054877 Antiadhesive carbohydrates |
| 03/08/2007 | US20070054841 Method of treatment of systemic injury secondary to burns |
| 03/08/2007 | US20070053852 Lipidic protein-transfer systems and cosmetic/dermatological use thereof |
| 03/08/2007 | US20070053833 Hydrating a leukemia patient; parenterally administering a dose samarium ethylenediaminetetramethylenephosphonic acid (EDTMP); and melphalan, busulfan, and/or cyclophosphamiide; anticarcinogenic, antitumor, and antantiproliferative agents; autoimmune, infectious , metabolic or genetic disorders |
| 03/08/2007 | DE102005042139A1 Verwendung von Enzianwurzel-Maische und entsprechende Mittel Use of gentian root mash and corresponding means |
| 03/08/2007 | CA2620685A1 Pharmaceutical composition comprising an iron chelator |
| 03/07/2007 | EP1758915A2 Composition and method for inhibiting platelet aggregation |
| 03/07/2007 | CN1926135A Cycloalkyl derivatives of 3-hydroxy-4-pyridinones |
| 03/07/2007 | CN1925862A Treatment of diseases associated with the EGR-1 enhancer element |
| 03/07/2007 | CN1303074C Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 03/06/2007 | US7186411 Vaccines absorbable by the transmucosal way |
| 03/01/2007 | WO2007024008A1 Preventive or therapeutic agent for side effect based on cytotoxicity of anticancer therapy containing apoptosis inhibition activity-enhancing protein fnk or nucleic acid encoding the same |
| 03/01/2007 | WO2007023931A1 Composition for prevention of increase in blood alcohol level |
| 03/01/2007 | WO2006096577A3 Methods of preventing and treating opioid bowel dysfunction |
| 03/01/2007 | US20070048392 Plant extract mixtures and their uses |
| 03/01/2007 | US20070048287 Molecular antigen array |
| 02/28/2007 | EP1757289A1 Composition for acceleration of alcohol metabolism or recuperation from fatigue through gluconeogenesis |
| 02/28/2007 | CN1919316A Multifunctional antisenescence health product and making method thereof |
| 02/28/2007 | CN1919216A Microbiological antioxidant and method for preparing same |
| 02/28/2007 | CN1301975C 1,2-diaryl benzimidazole derivative for treating illnesses associated with microglia activation |
| 02/28/2007 | CN1301720C Biological deodorization method for dried oviduct fat of forest frog |
| 02/28/2007 | CN1301710C Therapeutic methods and compositions involving isoflavones |
| 02/27/2007 | US7182965 pollen polyterpenes for the treatment of microbial, especially bacterial, diseases for topical, oral and parenteral administration in humans and animals |
| 02/22/2007 | WO2007021034A1 Scavenger of harmful active oxygen and/or free radical in living body |
| 02/22/2007 | US20070042995 Use of acetyl-d-aminoglycosamine in treatment of local lesions and systematic symptoms related to infections of virus or bacteria |
| 02/22/2007 | DE102005038740A1 Procedure and device for preventing the diseases of bees, comprises spraying electrolytically produced silver colloid as drink supply into the beehive and/or directly adding the silver colloid into the food supply of the bees |
| 02/22/2007 | CA2619769A1 Scavenger of in vivo harmful reactive oxygen species and/or free radicals |
| 02/21/2007 | EP1754702A1 Epigallocatechin dimers or trimers having lipase inhibitory activity and/or antioxidative activity |
| 02/21/2007 | CN1916016A Antiinflammation compound |
| 02/21/2007 | CN1916013A Pharmaceutical compounds |
| 02/20/2007 | US7179901 Renal regulatory elements and methods of use thereof |
| 02/20/2007 | CA2186784C The use of carboxylic acid derivatives as drugs |
| 02/15/2007 | WO2007019417A1 Oxazolopyridine derivatives as sirtuin modulators |
| 02/15/2007 | WO2007019345A1 Imidazopyridine derivatives as sirtuin modulating agents |
| 02/15/2007 | WO2007019344A1 Imidazo [2,1-b] thiazole derivatives as sirtuin modulating compounds |
| 02/15/2007 | WO2007018475A1 Novel anticoagulant polypeptides and complex |
| 02/15/2007 | WO2007018226A1 Prophylactic and/or therapeutic agent for corneal disorder |
| 02/15/2007 | WO2007017146A2 Use of collismycin and derivatives thereof as oxidative stress inhibitors |
| 02/15/2007 | WO2007016864A1 Use of fructus schisandrae and extracts thereof in preventing and decreasing toxic and side effects of antineoplastic drugs |
| 02/15/2007 | US20070037848 Treatment of neurological conditions |
| 02/15/2007 | US20070036877 Oral compositions and route of administration for the delivery of a thylakoid extract |
| 02/15/2007 | US20070036735 Skin external preparation |
| 02/15/2007 | DE10242062B4 Hydrierte kondensierte Palatinose, Verfahren zu deren Herstellung und deren Verwendung Hydrogenated condensed palatinose, processes for their preparation and their use |
| 02/15/2007 | CA2618370A1 Oxazolopyridine derivatives as sirtuin modulators |
| 02/15/2007 | CA2618368A1 Imidazopyridine derivatives as sirtuin modulating agents |
| 02/15/2007 | CA2617532A1 Imidazo [2,1-b] thiazole derivatives as sirtuin modulating compounds |
| 02/14/2007 | EP1752156A1 Active oxygen eliminator and moisturizer containing wild watermelon extract |
| 02/14/2007 | EP1750681A2 Decontaminant edible product, methods of production and uses thereof |
| 02/14/2007 | EP1417228B1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/14/2007 | EP1339701B1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 02/14/2007 | EP1267857B1 In vitro use of astaxanthin for pretreatment of cells prior to UV-exposure to inhibit the activation of NF-kB |
| 02/14/2007 | CN1913893A NK-1 receptor antagonists for improving anesthesia recovery |
| 02/14/2007 | CN1911253A Extractive of Abalone mushroom, extraction method and application thereof |
| 02/14/2007 | CN1911238A Composite used for skin, and its application method |
| 02/14/2007 | CN1911117A Mung bean and chrysanthemum flower beverage |
| 02/14/2007 | CN1300173C Human antibodies that bind huma TNF 'alpha' |
| 02/13/2007 | US7176164 1,3-selenazolin derivatives and process for preparing the same |
| 02/13/2007 | US7175859 aqueous extract of stems or leaves or stems and leaves of one or more Cissus quandragularis plants to promote weight loss; combined with chitosan and amylase inhibitor |
| 02/13/2007 | US7175842 Methods of modulating hair growth |